The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK blocks Shell paying Iran oil debt in food, medicine

Mon, 22nd Apr 2013 12:44

By Richard Mably

LONDON, April 22 (Reuters) - Britain has blocked efforts byoil major Royal Dutch Shell to settle a $2.3 billiondebt it owes Iran by paying in kind with grains orpharmaceuticals, industry sources said.

Shell has been trying for months to find a way to workaround international sanctions that prevent it paying incurrency for crude it bought from the National Iranian OilCompany before a European Union embargo on Iran that startedlast July.

The sources said the British government was reluctant toprovide relief for the Iranian economy when Western powers areusing sanctions to apply financial pressure on Tehran todismantle its nuclear programme.

"The view is that doesn't make sense to smooth the way for apayment that helps Iran when government is trying to press Iranto negotiate," said an industry source.

A government spokesman declined comment on the Shell casebut said: "The government fully backs the tough regime of EUsanctions that have been put in place against Iran."

Talks earlier this month between Iran and six world powersincluding Britain failed to make progress in resolving adecade-old dispute around Iran's nuclear progress. Another roundof negotiations has been scheduled for May 21.

The industry sources said Shell in February explored withthe British government the possibility of asking Britishpharmaceuticals maker GSK to deliver medicines to Iranin a payment-in-kind deal known as an offset agreement.

GSK said it had not been approached or held any discussionson the matter. Shell declined comment.

In October, the Anglo-Dutch oil company sought permissionfor an offset agreement that would have seen U.S. agriculturaltrader Cargill deliver grain to Iran.

Following publication by Reuters, Dutch foreign ministerFrans Timmermans in a letter to parliament acknowledged theproposal, saying: "As in all sanctions regimes there are somecarefully defined exceptions applicable for which in certaincases an exemption can be granted by national governments."

Meetings were held with Cargill but, said the industrysources, the proposal was turned down by the British government.Cargill and Shell both declined comment at the time.

MAINTAINING IRAN RELATIONSHIP

The sources said the oil company wanted to repay its debt toNIOC to maintain cordial relations with Iran, one of the biggestproducers in the Organization of the Petroleum ExportingCountries.

"Politics come and go but it's in the interests of Shell andits shareholders to pay its debts and maintain a relationshipwith a leading oil producer like Iran," said one of the sources.

Shell revealed in a March filing to U.S. regulatoryauthorities that it owed Tehran $2.3 billion and made a net lossof $6 million trading Iranian oil in 2012. Unlike its rivals,Shell continued trading with Iran under a provision forpre-existing contracts close to the EU's June 30 deadline beforethe embargo. The debt is for oil purchased in 2011 and 2012.

Iran's oil revenues have fallen by about 50 percent sincesanctions were imposed last year, and regional economistsbelieve it has been forced to draw on its foreign reserves tohelp buy essentials like grains.

But with an estimated $100 billion of foreign reserves atthe start of 2012, thanks to high oil prices, the Iranianeconomy is far from collapse.

The International Monetary Fund said last week that whilesanctions had frozen Iran out of the international bankingsystem, Tehran was avoiding a balance-of-payments crisis andshould emerge from recession in 2014.

Food and medicine are among the humanitarian goods notbarred by U.S. and European sanctions but, isolated frominternational banking, Iran has been forced to pay a premium forgrain imports.

Washington has tried to restrict countries like China,India, South Korea and Japan that still buy Iranian oil topaying for shipments by the barter of approved goods - includingfood and medicine.

U.S. sanctions state that funds used to pay for oil mustremain in a bank account in the purchasing country and can beused only for non-sanctioned, bilateral trade between thatcountry and Iran. Any bank that repatriates the money ortransfers it to a third country faces a U.S. sanction risk.

Nevertheless, said the industry sources, it appears theBritish government would rather Iran be obliged to spend foreignreserves or use oil revenues to barter for essential importsthan benefit from shipments of humanitarian goods paid for byShell debt.

More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.